Hanimune Therapeutics
Hanimune Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
About Hanimune Therapeutics
Based in the United States, Hanimune Therapeutics is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Hanimune Therapeutics develops consumer food products designed to prevent and manage food allergies by delivering controlled doses of common allergens to build tolerance, including products like 'Lil Mixins' for early infant allergen introduction and 'Top9Proteins' formulations with consistent allergen quantities.
Explore Hanimune Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.